About Mexico Centre for Clinical Research
Clinical Trials at Mexico Centre for Clinical Research
During the past decade, Mexico Centre for Clinical Research conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 7 clinical trials were completed, i.e. on
average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 3 clinical trials were completed. i.e. 42.9%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mexico Centre for Clinical Research" #1 sponsor was "Hoffmann-La Roche" with 6 trials, followed by "Janssen Research & Development, LLC" with 3 trials
sponsored, "AstraZeneca" with 1 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored and "Eli Lilly and Company"
with 1 trials sponsored. Other sponsors include -2 different institutions and
companies that sponsored additional 8 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mexico Centre for Clinical Research"
#1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Mexico Centre for Clinical Research
According to Clinical.Site data, the most researched conditions in "Mexico Centre for Clinical Research" are
"Rheumatoid Arthritis" (3 trials), "Alzheimer Disease" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Relapsing Multiple Sclerosis" (2 trials) and "Alzheimer's Disease" (1 trials). Many other conditions were trialed in "Mexico Centre for Clinical Research" in a lesser frequency.
Clinical Trials Intervention Types at Mexico Centre for Clinical Research
Most popular intervention types in "Mexico Centre for Clinical Research" are "Drug" (15 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (8 trials), "Amivantamab" (2 trials), "Fenebrutinib" (2 trials), "Gantenerumab" (2 trials) and "Ocrelizumab" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Mexico Centre for Clinical Research
The vast majority of trials in "Mexico Centre for Clinical Research" are
14 trials for "All" genders and 1 trials for "Male" genders.
Clinical Trials Status at Mexico Centre for Clinical Research
Currently, there are NaN active trials in "Mexico Centre for Clinical Research".
1 are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 5 completed trials in Mexico Centre for Clinical Research,
undefined suspended trials,
and 4 terminated clinical trials to date.
Out of the total trials that were conducted in Mexico Centre for Clinical Research, 0 "Phase 1"
clinical trials were conducted, 3 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".